These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38492007)

  • 1. Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics.
    Cantone E; D'Ascanio L; De Luca P; Roccamatisi D; La La Mantia I; Brenner MJ; Di Stadio A
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3671-3678. PubMed ID: 38492007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial.
    Di Stadio A; Gallina S; Cocuzza S; De Luca P; Ingrassia A; Oliva S; Sireci F; Camaioni A; Ferreli F; Mercante G; Gaino F; Pace GM; La Mantia I; Brenner MJ
    Eur Arch Otorhinolaryngol; 2023 Nov; 280(11):4949-4961. PubMed ID: 37380908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial.
    Di Stadio A; D'Ascanio L; Vaira LA; Cantone E; De Luca P; Cingolani C; Motta G; De Riu G; Vitelli F; Spriano G; De Vincentiis M; Camaioni A; La Mantia I; Ferreli F; Brenner MJ
    Curr Neuropharmacol; 2022; 20(10):2001-2012. PubMed ID: 35450527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin": preliminary results.
    D'Ascanio L; Vitelli F; Cingolani C; Maranzano M; Brenner MJ; Di Stadio A
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4156-4162. PubMed ID: 34156697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parosmia COVID-19 Related Treated by a Combination of Olfactory Training and Ultramicronized PEA-LUT: A Prospective Randomized Controlled Trial.
    Di Stadio A; Cantone E; De Luca P; Di Nola C; Massimilla EA; Motta G; La Mantia I; Motta G
    Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study.
    De Luca P; Camaioni A; Marra P; Salzano G; Carriere G; Ricciardi L; Pucci R; Montemurro N; Brenner MJ; Di Stadio A
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of classical olfactory training in patients with COVID-19-related persistent loss of smell.
    Yaylacı A; Azak E; Önal A; Aktürk DR; Karadenizli A
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):757-763. PubMed ID: 35904631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified Olfactory Training Is an Effective Treatment Method for COVID-19 Induced Parosmia.
    Altundag A; Yilmaz E; Kesimli MC
    Laryngoscope; 2022 Jul; 132(7):1433-1438. PubMed ID: 35257391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of smell training on COVID-19 induced smell loss.
    Schepens EJA; de Haas CJM; Postma EM; van Dijk B; Boesveldt S; Stegeman I; Kamalski DMA
    Rhinology; 2024 Aug; 62(4):386-393. PubMed ID: 38446154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Olfactory Disorders After SARS - CoViD 2 Virus Infection.
    Schmidt F; Azar C; Goektas O
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):48S-53S. PubMed ID: 36976171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaining Back What Is Lost: Recovering the Sense of Smell in Mild to Moderate Patients After COVID-19.
    Iannuzzi L; Salzo AE; Angarano G; Palmieri VO; Portincasa P; Saracino A; Gelardi M; Dibattista M; Quaranta N
    Chem Senses; 2020 Dec; 45(9):875-881. PubMed ID: 33033827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trigeminal function in patients with COVID-associated olfactory loss.
    Juratli JH; Garefis K; Konstantinidis I; Hummel T
    Eur Arch Otorhinolaryngol; 2024 May; 281(5):2403-2411. PubMed ID: 38127097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-lipoic acid does not improve olfactory training results in olfactory loss due to COVID-19: a double-blind randomized trial.
    Figueiredo LP; Paim PVDSL; Cerqueira-Silva T; Barreto CC; Lessa MM
    Braz J Otorhinolaryngol; 2024; 90(1):101356. PubMed ID: 37944311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory Training Impacts Olfactory Dysfunction Induced by COVID-19: A Pilot Study.
    Bérubé S; Demers C; Bussière N; Cloutier F; Pek V; Chen A; Bolduc-Bégin J; Frasnelli J
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(2):57-66. PubMed ID: 36529118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal insulin for COVID-19-related smell loss.
    Daniel D; Paula LN; Eduardo BM; Daniel GA; Andrea DE; Fernando LN; Armando MC
    Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):201-205. PubMed ID: 37608216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.
    Gary JB; Gallagher L; Joseph PV; Reed D; Gudis DA; Overdevest JB
    Am J Rhinol Allergy; 2023 Jan; 37(1):95-101. PubMed ID: 35957578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training.
    Liu DT; Sabha M; Damm M; Philpott C; Oleszkiewicz A; Hähner A; Hummel T
    Laryngoscope; 2021 Mar; 131(3):618-623. PubMed ID: 33210732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of olfactory training in COVID-19 patients with olfactory dysfunction: a prospective study.
    Lechien JR; Vaira LA; Saussez S
    Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1255-1263. PubMed ID: 36153785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parosmia in patients with post-infectious olfactory dysfunction in the era of COVID-19-associated olfactory impairment.
    Gunder N; Hummel T
    HNO; 2024 Sep; 72(9):649-656. PubMed ID: 38935276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-rich plasma injection in the olfactory clefts of COVID-19 patients with long-term olfactory dysfunction.
    Lechien JR; Le Bon SD; Saussez S
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2351-2358. PubMed ID: 36520209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.